Pioneer in phage-based diagnostics

Twitter Youtube Linkedin Envelope
  • Home
  • About PBD Biotech
    • About
    • Research
    • Blog
  • Phage-based diagnostics
  • Animal Health
    • Animal Health
    • Bovine TB
    • Johne’s Disease
    • Dairy Industry
  • Human Health
  • Contact us
  • Home
  • About PBD Biotech
    • About
    • Research
    • Blog
  • Phage-based diagnostics
  • Animal Health
    • Animal Health
    • Bovine TB
    • Johne’s Disease
    • Dairy Industry
  • Human Health
  • Contact us

Human Health

Loading...
No persistent cough in 4 out of 5 with Tuberculosis Lancet paper reveals

No persistent cough in 4 out of 5 with Tuberculosis Lancet paper reveals

March 21, 2024
80 percent of people with tuberculosis (TB), the world’s most deadly infection, do not have a persistent cough and yet are still infective, according to a study led by Amsterdam UMC, published in the Lancet. 
No persistent cough in 4 out of 5 with Tuberculosis Lancet paper reveals

No persistent cough in 4 out of 5 with Tuberculosis Lancet paper reveals

March 21, 2024
80 percent of people with tuberculosis (TB), the world’s most deadly infection, do not have a persistent cough and yet...
Lancet article - PET-CT features observed following M tuberculosis exposure. biomarkers show those at high risk of TB

Identifying people at risk of developing TB

January 23, 2024
A novel approach to studying the progression of tuberculosis (TB) from infection to disease has identified and treated people at increased risk of developing the disease that current methods of testing would not.
Lancet article - PET-CT features observed following M tuberculosis exposure. biomarkers show those at high risk of TB

Identifying people at risk of developing TB

January 23, 2024
A novel approach to studying the progression of tuberculosis (TB) from infection to disease has identified and treated people at...
ECCMID

Actiphage TB diagnostic finds live mycobacterium tuberculosis in the blood of people with incipient TB

April 23, 2022
A clinical trial of Actiphage, a promising new diagnostic for tuberculosis infection, has shown for the first time that live bacteria can be detected in the blood of people with incipient TB infection.
ECCMID

Actiphage TB diagnostic finds live mycobacterium tuberculosis in the blood of people with incipient TB

April 23, 2022
A clinical trial of Actiphage, a promising new diagnostic for tuberculosis infection, has shown for the first time that live...

Rapid blood test offers new hope for people most at risk of TB

March 3, 2022
A quarter of a million children die of tuberculosis (TB) each year worldwide. Early diagnosis would help save lives.

Rapid blood test offers new hope for people most at risk of TB

March 3, 2022
A quarter of a million children die of tuberculosis (TB) each year worldwide. Early diagnosis would help save lives.

Human TB study into new blood test achieves funding following successful proof of concept

December 27, 2019
Worldwide a quarter of a million children die of tuberculosis (TB) each year, early diagnosis would help to save their lives but most are unable to produce the sample of mucus that is needed for the current test.

Human TB study into new blood test achieves funding following successful proof of concept

December 27, 2019
Worldwide a quarter of a million children die of tuberculosis (TB) each year, early diagnosis would help to save their...

developers of phage-based diagnostics

Contact Us

Registered Company Address
B4 Parkside Knowledge Gateway
Nesfield Road
Colchester
CO4 3ZL
United Kingdom

info@pbdbio.com

BIVDA member 2023
Twitter Youtube Linkedin

Privacy and cookies policy

© 2025 PBD Biotech Ltd

design: out of house